TGA review could improve new medicines access: Medicines Australia

new antibiotics: gloved hands holding two antibiotic capsules
Medicines Australia has welcomed the recommendations of an independent review into the TGA which, if adopted, will help to cut time delays and improve Australian’s access to innovative new medicines, it says. The Review examined the TGA’s regulatory framework and processes with a view to identifying areas of unnecessary red tape and opportunities to enhance

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous National Student Business Plan Competition quarter-finalists announced
Next Drug companies cause slow access to new medicines: Ley